Scott Keigan

Scott Keigan
Scott joined Oligo Factory in June of 2025, coming from SomaLogic where he served as a Senior Manager of Life Sciences spearheading the launch and expansion of cutting-edge proteomics and AI technologies through strategic collaborations with top biotechnology and medical experts across the US and Canada.
Prior to SomaLogic, Scott spent seven years at Integrated DNA Technologies (IDT), where he developed deep technical expertise in oligo synthesis for NGS, qPCR, and CRISPR, later leading sales initiatives that expanded IDT’s footprint in life sciences, diagnostics, and therapeutics across the central and western US.
Holding a B.S. in Evolutionary Biology from the University of Tennessee and an M.Sc. from the University of Exeter, Scott blends scientific rigor and curiosity with strategic planning and trusted industry relationships. His commitment to advancing science and medical care aligns with Oligo Factory’s mission to deliver innovative, accessible solutions to the biotech sector.